Brief: Bergenbio Presents COVID-19 Data In Late-Breaking Abstract On bemcentinib

Oncoinvent ASA

29/06/2021 06:12

June 29 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO PRESENTING COVID-19 DATA IN LATE-BREAKING
ABSTRACT
PRESENTATION
    * RESULTS SHOWED THAT FROM BASELINE TO DAY 29, THERE WERE
FEWER
DEATHS IN BEMCENTINIB TREATED PATIENTS (2 OF 58 AND 1 OF 28)
VERSUS SOC (3 OF 57 AND 5 OF 32) FOR BGBC020 AND ACCORD2
RESPECTIVELY
    * BEMCENTINIB WAS WELL TOLERATED THROUGHOUT BOTH STUDIES

Source text for Eikon:  ID:nObitpRyZa 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))